Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing

J Vasc Surg. 2013 Sep;58(3):766-75.e12. doi: 10.1016/j.jvs.2012.11.095. Epub 2013 Jun 4.

Abstract

Objective: The present study is designed to understand the contribution of peripheral vascular disease and peripheral neuropathy to the wound-healing impairment associated with diabetes. Using a rabbit model of diabetic neuroischemic wound healing, we investigated rate of healing, leukocyte infiltration, and expression of cytokines, interleukin-8 and interleukin-6, and neuropeptides, substance P, and neuropeptide Y.

Methods: Diabetes was induced in New Zealand White rabbits by administering alloxan while control rabbits received saline. Ten days later, animals in both groups underwent surgery. One ear served as a sham, and the other was made ischemic (ligation of central+rostral arteries) or neuroischemic (ischemia+ resection of central+rostral nerves). Four 6-mm punch biopsy wounds were created in both ears and wound healing was followed for 10 days using computerized planimetry.

Results: Nondiabetic sham and ischemic wounds healed significantly more rapidly than diabetic sham and ischemic wounds. Healing was slowest in neuroischemic wounds, irrespective of diabetic status. A high M1/M2 macrophage ratio and a high proinflammatory cytokine expression, both indicators of chronic proinflammatory state, and low neuropeptide expression were seen in preinjury diabetic skin. Postinjury, in diabetic wounds, the M1/M2 ratio remained high, the reactive increase in cytokine expression was low, and neuropeptide expression was further decreased in neuroischemic wounds.

Conclusions: This rabbit model illustrates how a combination of a high M1/M2 ratio, a failure to mount postinjury cytokine response as well as a diminished neuropeptide expression, contribute to wound-healing impairment in diabetes. The addition of neuropathy to ischemia leads to equivalently severe impaired wound-healing irrespective of diabetes status, suggesting that in the presence of ischemia, loss of neuropeptide function contributes to the impaired healing associated with diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetic Angiopathies / etiology*
  • Diabetic Angiopathies / genetics
  • Diabetic Angiopathies / immunology
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / pathology
  • Diabetic Neuropathies / etiology*
  • Diabetic Neuropathies / genetics
  • Diabetic Neuropathies / immunology
  • Diabetic Neuropathies / metabolism
  • Diabetic Neuropathies / pathology
  • Down-Regulation
  • Inflammation Mediators / metabolism*
  • Ischemia / etiology*
  • Ischemia / genetics
  • Ischemia / immunology
  • Ischemia / metabolism
  • Ischemia / pathology
  • Macrophages / immunology
  • Neuropeptides / genetics
  • Neuropeptides / metabolism*
  • Rabbits
  • Skin Ulcer / etiology*
  • Skin Ulcer / genetics
  • Skin Ulcer / immunology
  • Skin Ulcer / metabolism
  • Skin Ulcer / pathology
  • Skin* / immunology
  • Skin* / metabolism
  • Skin* / pathology
  • Time Factors
  • Up-Regulation
  • Wound Healing*

Substances

  • Cytokines
  • Inflammation Mediators
  • Neuropeptides